# Flowserve Corp: financial statements, quarterly

FLS · NYSE · CIK 30625 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fls.md) · [Financials](/companies/fls/financials.md) · [Filings](/companies/fls/filings.md) · [Insiders](/companies/fls/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fls/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,165 d](/filings/0000030625-26-000003.md) | [1,087](/filings/0000030625-25-000059.md) | [1,157](/filings/0000030625-25-000066.md) | [1,133](/filings/0000030625-25-000072.md) | [1,180 d](/filings/0000030625-26-000003.md) | [1,145](/filings/0000030625-26-000012.md) | [1,188](/filings/0000030625-26-000020.md) | [1,174](/filings/0000030625-26-000026.md) | [1,222 d](/filings/0000030625-26-000003.md) | [1,068](/filings/0000030625-26-000012.md) | [1,169](/filings/0000030625-26-000020.md) | [1,238](/filings/0000030625-26-000026.md) |
| Cost of revenue | $m | [826 d](/filings/0000030625-26-000003.md) | [749](/filings/0000030625-25-000059.md) | [791](/filings/0000030625-25-000066.md) | [776](/filings/0000030625-25-000072.md) | [808 d](/filings/0000030625-26-000003.md) | [775](/filings/0000030625-26-000012.md) | [782](/filings/0000030625-26-000020.md) | [794](/filings/0000030625-26-000026.md) | [797 d](/filings/0000030625-26-000003.md) | [688](/filings/0000030625-26-000012.md) | [784](/filings/0000030625-26-000020.md) | [823](/filings/0000030625-26-000026.md) |
| Gross profit | $m | [340 d](/filings/0000030625-26-000003.md) | [339](/filings/0000030625-25-000059.md) | [366](/filings/0000030625-25-000066.md) | [357](/filings/0000030625-25-000072.md) | [372 d](/filings/0000030625-26-000003.md) | [369](/filings/0000030625-26-000012.md) | [407](/filings/0000030625-26-000020.md) | [380](/filings/0000030625-26-000026.md) | [425 d](/filings/0000030625-26-000003.md) | [380](/filings/0000030625-26-000012.md) | [385](/filings/0000030625-26-000020.md) | [414](/filings/0000030625-26-000026.md) |
| Selling, general and administrative | $m | [235 d](/filings/0000030625-26-000003.md) | [228](/filings/0000030625-25-000059.md) | [239](/filings/0000030625-25-000066.md) | [259](/filings/0000030625-25-000072.md) | [252 d](/filings/0000030625-26-000003.md) | [243](/filings/0000030625-26-000012.md) | [266](/filings/0000030625-26-000020.md) | [305](/filings/0000030625-26-000026.md) | [248 d](/filings/0000030625-26-000003.md) | [263](/filings/0000030625-26-000012.md) | [266](/filings/0000030625-26-000020.md) | [282](/filings/0000030625-26-000026.md) |
| Operating income | $m | [109 d](/filings/0000030625-26-000003.md) | [113](/filings/0000030625-25-000059.md) | [121](/filings/0000030625-25-000066.md) | [103](/filings/0000030625-25-000072.md) | [125 d](/filings/0000030625-26-000003.md) | [132](/filings/0000030625-26-000012.md) | [147](/filings/0000030625-26-000020.md) | [79.3](/filings/0000030625-26-000026.md) | [42.2 d](/filings/0000030625-26-000003.md) | [119](/filings/0000030625-26-000012.md) | [151](/filings/0000030625-26-000020.md) | [155](/filings/0000030625-26-000026.md) |
| Interest expense | $m | [16.9 d](/filings/0000030625-26-000003.md) | [15.3](/filings/0000030625-25-000059.md) | [16.9](/filings/0000030625-25-000066.md) | [16.6](/filings/0000030625-25-000072.md) | [20.5 d](/filings/0000030625-26-000003.md) | [19.2](/filings/0000030625-26-000012.md) | [20.3](/filings/0000030625-26-000020.md) | [18.7](/filings/0000030625-26-000026.md) | [19.6 d](/filings/0000030625-26-000003.md) | [20.4](/filings/0000030625-26-000012.md) | [25.7](/filings/0000030625-26-000020.md) | [26.6](/filings/0000030625-26-000026.md) |
| Income tax | $m | [4.0 d](/filings/0000030625-26-000003.md) | [20.1](/filings/0000030625-25-000059.md) | [23.8](/filings/0000030625-25-000066.md) | [18.7](/filings/0000030625-25-000072.md) | [22.2 d](/filings/0000030625-26-000003.md) | [17.7](/filings/0000030625-26-000012.md) | [15.6](/filings/0000030625-26-000020.md) | [93.7](/filings/0000030625-26-000026.md) | [28.5 d](/filings/0000030625-26-000003.md) | [21.1](/filings/0000030625-26-000012.md) | [17.1](/filings/0000030625-26-000020.md) | [15.1](/filings/0000030625-26-000026.md) |
| Net income | $m | [62.6 d](/filings/0000030625-26-000003.md) | [74.2](/filings/0000030625-25-000059.md) | [72.6](/filings/0000030625-25-000066.md) | [58.4](/filings/0000030625-25-000072.md) | [77.5 d](/filings/0000030625-26-000003.md) | [73.9](/filings/0000030625-26-000012.md) | [81.8](/filings/0000030625-26-000020.md) | [220](/filings/0000030625-26-000026.md) | [(29.0) d](/filings/0000030625-26-000003.md) | [81.7](/filings/0000030625-26-000012.md) | [99.0](/filings/0000030625-26-000020.md) | [103](/filings/0000030625-26-000026.md) |
| Diluted EPS | $ per share | not reported | [0.56](/filings/0000030625-25-000059.md) | [0.55](/filings/0000030625-25-000066.md) | [0.44](/filings/0000030625-25-000072.md) | not reported | [0.56](/filings/0000030625-26-000012.md) | [0.62](/filings/0000030625-26-000020.md) | [1.67](/filings/0000030625-26-000026.md) | not reported | [0.64](/filings/0000030625-26-000012.md) | [0.77](/filings/0000030625-26-000020.md) | [0.81](/filings/0000030625-26-000026.md) |
| Basic EPS | $ per share | not reported | [0.56](/filings/0000030625-25-000059.md) | [0.55](/filings/0000030625-25-000066.md) | [0.44](/filings/0000030625-25-000072.md) | not reported | [0.56](/filings/0000030625-26-000012.md) | [0.62](/filings/0000030625-26-000020.md) | [1.69](/filings/0000030625-26-000026.md) | not reported | [0.64](/filings/0000030625-26-000012.md) | [0.78](/filings/0000030625-26-000020.md) | [0.81](/filings/0000030625-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [546](/filings/0000030625-25-000039.md) | not reported | not reported | not reported | [675](/filings/0000030625-26-000003.md) | not reported | not reported | not reported | [760](/filings/0000030625-26-000003.md) | not reported | not reported | not reported |
| Current assets | $m | [2,704](/filings/0000030625-25-000039.md) | [2,767](/filings/0000030625-24-000041.md) | [2,816](/filings/0000030625-24-000081.md) | [2,870](/filings/0000030625-24-000092.md) | [2,904](/filings/0000030625-26-000003.md) | [2,865](/filings/0000030625-25-000059.md) | [3,004](/filings/0000030625-25-000066.md) | [3,165](/filings/0000030625-25-000072.md) | [3,043](/filings/0000030625-26-000026.md) | [3,055](/filings/0000030625-26-000012.md) | [3,119](/filings/0000030625-26-000020.md) | [3,129](/filings/0000030625-26-000026.md) |
| Total assets | $m | [5,109](/filings/0000030625-26-000003.md) | [5,150](/filings/0000030625-25-000059.md) | [5,164](/filings/0000030625-25-000066.md) | [5,275](/filings/0000030625-25-000072.md) | [5,501](/filings/0000030625-26-000003.md) | [5,483](/filings/0000030625-26-000012.md) | [5,683](/filings/0000030625-26-000020.md) | [5,830](/filings/0000030625-26-000026.md) | [5,708](/filings/0000030625-26-000026.md) | [5,733](/filings/0000030625-26-000012.md) | [6,320](/filings/0000030625-26-000020.md) | [6,347](/filings/0000030625-26-000026.md) |
| Current liabilities | $m | [1,439](/filings/0000030625-25-000039.md) | [1,474](/filings/0000030625-24-000041.md) | [1,406](/filings/0000030625-24-000081.md) | [1,440](/filings/0000030625-24-000092.md) | [1,468](/filings/0000030625-26-000003.md) | [1,382](/filings/0000030625-25-000059.md) | [1,430](/filings/0000030625-25-000066.md) | [1,505](/filings/0000030625-25-000072.md) | [1,502](/filings/0000030625-26-000026.md) | [1,378](/filings/0000030625-26-000012.md) | [1,449](/filings/0000030625-26-000020.md) | [1,491](/filings/0000030625-26-000026.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [1,167](/filings/0000030625-25-000039.md) | [1,152](/filings/0000030625-24-000041.md) | [1,212](/filings/0000030625-24-000081.md) | [1,173](/filings/0000030625-24-000092.md) | [1,460](/filings/0000030625-26-000003.md) | [1,451](/filings/0000030625-25-000059.md) | [1,441](/filings/0000030625-25-000066.md) | [1,436](/filings/0000030625-25-000072.md) | [1,525](/filings/0000030625-26-000026.md) | [1,662](/filings/0000030625-26-000012.md) | [2,122](/filings/0000030625-26-000020.md) | [2,047](/filings/0000030625-26-000026.md) |
| Current portion of debt | $m | [66.2](/filings/0000030625-24-000092.md) | [66.4](/filings/0000030625-24-000041.md) | [66.4](/filings/0000030625-24-000081.md) | [66.9](/filings/0000030625-24-000092.md) | [44.1](/filings/0000030625-25-000072.md) | [44.2](/filings/0000030625-25-000059.md) | [44.9](/filings/0000030625-25-000066.md) | [46.4](/filings/0000030625-25-000072.md) | [49.9](/filings/0000030625-26-000026.md) | [53.0](/filings/0000030625-26-000012.md) | [12.7](/filings/0000030625-26-000020.md) | [9.9](/filings/0000030625-26-000026.md) |
| Shareholders' equity | $m | [1,936](/filings/0000030625-25-000039.md) | [1,954](/filings/0000030625-24-000041.md) | [1,970](/filings/0000030625-24-000081.md) | [2,054](/filings/0000030625-24-000092.md) | [2,008](/filings/0000030625-26-000003.md) | [2,080](/filings/0000030625-25-000059.md) | [2,223](/filings/0000030625-25-000066.md) | [2,264](/filings/0000030625-25-000072.md) | [2,191](/filings/0000030625-26-000026.md) | [2,212](/filings/0000030625-26-000012.md) | [2,260](/filings/0000030625-26-000020.md) | [2,312](/filings/0000030625-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [195 d](/filings/0000030625-26-000003.md) | [62.3](/filings/0000030625-25-000059.md) | [(12.8) d](/filings/0000030625-25-000066.md) | [178 d](/filings/0000030625-25-000072.md) | [197 d](/filings/0000030625-26-000003.md) | [(49.9)](/filings/0000030625-26-000012.md) | [154 d](/filings/0000030625-26-000020.md) | [402 d](/filings/0000030625-26-000026.md) | [(0.2) d](/filings/0000030625-26-000003.md) | [(43.1)](/filings/0000030625-26-000012.md) | [129 d](/filings/0000030625-26-000020.md) | [144 d](/filings/0000030625-26-000026.md) |
| Capital expenditure | $m | [19.8 d](/filings/0000030625-26-000003.md) | [13.6](/filings/0000030625-25-000059.md) | [14.7](/filings/0000030625-25-000066.md) | [23.9](/filings/0000030625-25-000072.md) | [28.9 d](/filings/0000030625-26-000003.md) | [11.7](/filings/0000030625-26-000012.md) | [16.6](/filings/0000030625-25-000066.md) | [17.2](/filings/0000030625-25-000072.md) | [25.4 d](/filings/0000030625-26-000003.md) | [16.9](/filings/0000030625-26-000012.md) | [16.9 d](/filings/0000030625-26-000020.md) | [17.2 d](/filings/0000030625-26-000026.md) |
| Dividends paid | $m | [26.2 d](/filings/0000030625-26-000003.md) | [27.7](/filings/0000030625-25-000059.md) | [27.6 d](/filings/0000030625-25-000066.md) | [27.6 d](/filings/0000030625-25-000072.md) | [27.6 d](/filings/0000030625-26-000003.md) | [27.6](/filings/0000030625-26-000012.md) | [27.6 d](/filings/0000030625-26-000020.md) | [27.5 d](/filings/0000030625-26-000026.md) | [27.0 d](/filings/0000030625-26-000003.md) | [26.7](/filings/0000030625-26-000012.md) | [28.1 d](/filings/0000030625-26-000020.md) | [28.0 d](/filings/0000030625-26-000026.md) |
| Share repurchases | $m | [0.0 d](/filings/0000030625-26-000003.md) | [2.5](/filings/0000030625-25-000059.md) | [13.6 d](/filings/0000030625-25-000066.md) | [3.9 d](/filings/0000030625-25-000072.md) | [0.0 d](/filings/0000030625-26-000003.md) | [21.1](/filings/0000030625-26-000012.md) | [31.7 d](/filings/0000030625-26-000020.md) | [145 d](/filings/0000030625-26-000026.md) | [56.9 d](/filings/0000030625-26-000003.md) | [0.0](/filings/0000030625-26-000012.md) | [25.0 d](/filings/0000030625-26-000020.md) | [50.0 d](/filings/0000030625-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [132](/filings/0000030625-24-000041.md) | [132](/filings/0000030625-24-000081.md) | [132](/filings/0000030625-24-000092.md) | [132](/filings/0000030625-25-000059.md) | [132](/filings/0000030625-25-000066.md) | [132](/filings/0000030625-25-000072.md) | [133](/filings/0000030625-26-000012.md) | [132](/filings/0000030625-26-000020.md) | [131](/filings/0000030625-26-000026.md) | [129](/filings/0000030625-26-000012.md) | [128](/filings/0000030625-26-000020.md) | [128](/filings/0000030625-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 126,806,088 at 2026-10-20, from the cover of the [10-Q filed 2026-10-28](/filings/0000030625-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:12 ET. No prices; not investment advice.